E-prostanoid 2 receptors dampen mast cell degranulation via cAMP/PKA-mediated suppression of IgE-dependent signaling

Journal of Leukocyte Biology

Volumn 92, Issue 6, 2012, Pages 1155-1165

  Serra Pages, Mariona ^a,b   Olivera, Ana ^a   Torres, Rosa ^b,c   Picado, César ^c   de Mora, Fernando ^b   Rivera, Juan ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Butaprost calcium; Fc I; Fyn; PGE2

Indexed keywords

BUTAPROST; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN E; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E2; PROTEIN KINASE B; PROTEIN KINASE FYN; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IN VITRO STUDY; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ALPROSTADIL; ANIMALS; CALCIUM; CELL DEGRANULATION; CELL LINE; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; FEMALE; GENE SILENCING; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; MICE; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; SIGNAL TRANSDUCTION;

ACARI; ANIMALIA;

EID: 84870475045     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0212109     Document Type: Article

References (52)

1. Melillo, E., Woolley, K. L., Manning, P. J., Watson, R. M., O'Byrne, P. M. (1994) Effects of inhaled PGE2 on exercise-induced bronchoconstriction and urinary LTC4 excretion in aspirin-sensitive asthmatics. Am. J. Respir. Crit. Care Med. 153, 572-575.
2. Gauvreau, G. M., Watson, R. M., O'Byrne, P. M. (1999) Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am. J. Respir. Crit. Care Med. 159, 31-36.
3. Pierzchalska, M., Szabó Z., Sanak, M., Soja, J., Szczeklik, A. (2003) Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. J. Allergy Clin. Immunol. 111, 1041-1048.
4. Perez-Novo, C. A., Watelet, J. B., Claeys, C., Van Cauwenberge, P., Bachert, C. (2005) Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J. Allergy Clin. Immunol. 115, 1189-1196.
5. Roca-Ferrer, J., Garcia-Garcia, F. J., Pereda, J., Perez-Gonzalez, M., Pujols, L., Alobid, I., Mullol, J., Picado, C. (2011) Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. J. Allergy Clin. Immunol. 128, 66-72.
6. Herrerias, A., Torres, R., Serra, M., Marco, A., Roca-Ferrer, J., Picado, C., de Mora, F. (2009) Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice. Int. Arch. Allergy Immunol. 149, 323-332.
7. Gavett, S. H., Madison, S. L., Chulada, P. C., Scarborough, P. E., Qu, W., Boyle, J. E., Tiano, H. F., Lee, C. A., Lagenbach, R., Roggli, V. L., Zeldin, D. C. (1999) Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J. Clin. Invest. 104, 721-732.
8. Peebles, R. S. J., Hashimoto, K., Morrow, J. D., Dworski, R., Collins, R. D., Hashimoto, Y., Christman, J. W., Kang, K. H., Jarzecka, K., Furlong, J., Mitchell, D. B., Talati, M., Graham, B. S., Sheller, J. R. (2002) Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 165, 1154-1160.
9. Nakata, J., Kondo, M., Tamaoki, J., Takemiya, T., Nohara, M., Yamagata, K., Nagai, A. (2005) Augmentation of allergic inflammation in the airways of cyclooxygenase-2 deficient mice. Respirology 10, 149-156.
10. Torres, R., Herrerias, A., Serra, M., Roca-Ferrer, J., Pujols, L., Marco, A., Picado, C., de Mora, F. (2008) An intranasal selective antisense oligonucleotide impairs lung cyclooxygenase-2 production and improves inflammation, but worsens airway function, in house dust mite sensitive mice. Respir. Res. 9, 72.
11. Torres, R., Pérez, M., Marco, A., Picado, C., de Mora, F. (2009) A cyclooxygenase- 2 selective inhibitor worsens respiratory function and enhances mast cell activity in ovalbumin-sensitized mice. Arch. Bronconeumol. 45, 162-167.
12. Harizi, H., Juzan, M., Pitard, V., Moreau, J. F., Gualde, N. (2002) Cyclooxygenase- 2-issued prostaglandin E(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 168, 2255-2263.
13. Duffy, S. M., Cruse, G., Cockerill, S. L., Brightling, C. E., Bradding, P. (2008) Engagement of the EP2 prostanoid receptor closes the K channel KCa3.1 in human lung mast cells and attenuates their migration. Eur. J. Immunol. 38, 2548-2556.
14. Feng, C., Beller, E. M., Bagga, S., Boyce, J. A. (2006) Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. Blood 107, 3243-3250.
15. Kay, L. J., Yeo, W. W., Peachell, P. T. (2006) Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br. J. Pharmacol. 147, 707-713.
16. Holgate, S. T., Hardy, C., Robinson, C., Agius, R. M., Howarth, P. H. (1986) The mast cell as a primary effector cell in the pathogenesis of asthma. J. Allergy Clin. Immunol. 77, 274-282.
17. Williams, C. M., Galli, S. J. (2000) The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105, 847-859.
18. Chung, K. F. (2005) Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma. Sci. STKE 2005, pe47.
19. Gomi, K., Zhu, F. G., Marshall, J. S. (2000) Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3- dependent mechanism. J. Immunol. 165, 6545-6552.
20. Kuehn, H. S., Jung, M. Y., Beaven, M. A., Metcalfe, D. D., Gilfillan, A. M. (2011) Distinct PGE(2)-responder and non-responder phenotypes in human mast cell populations: "all or nothing" enhancement of antigen- dependent mediator release. Immunol. Lett. 141, 45-54.
21. Razin, E. (1990) Culture of bone marrow-derived mast cells: a model for studying oxidative metabolism of arachidonic acid and synthesis of other molecules derived from membrane phospholipids. Methods Enzymol. 187, 514-520.
22. Regan, J. W., Bailey, T. J., Pepperl, D. J., Pierce, K. L., Bogardus, A. M., Donello, J. E., Fairbairn, C. E., Kedzie, K. M., Woodward, D. F., Gil, D. W. (1994) Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46, 213-220.
23. Alvarez-Errico, D., Yamashita, Y., Suzuki, R., Odom, S., Furumoto, Y., Yamashita, T., Rivera, J. (2010) Functional analysis of Lyn kinase A and B isoforms reveals redundant and distinct roles in FcRI-dependent mast cell activation. J. Immunol. 184, 5000-5008.
24. Tilley, S. L., Audoly, L. P., Hicks, E. H., Kim, H. S., Flannery, P. J., Coffman, T. M., Koller, B. H. (1999) Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J. Clin. Invest. 103, 1539-1545.
25. Saitoh, S., Arudchandran, R., Manetz, T. S., Zhang, W., Sommers, C. L., Love, P. E., Rivera, J., Samelson, L. E. (2000) LAT is essential for FcRI-mediated mast cell activation. Immunity 12, 525-535.
26. Parravicini, V., Gadina, M., Kovarova, M., Odom, S., Gonzalez-Espinosa, C., Furumoto, Y., Saitoh, S., Samelson, L. E., O'Shea, J. J., Rivera, J. (2002) Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3, 741-748.
27. Tsai, M., Hunt, J., Arm, J. P., London, C., Gurish, M., Galli, S. J. (1996) Cl.MC/C57.1 (C57) mouse mast cell line is of BALB/c origin and tumorigenic in BALB/c mice. FASEB J. 10, A1253.
28. Kirshenbaum, A. S., Akin, C., Wu, Y., Rottem, M., Goff, J. P., Beaven, M. A., Rao, V. K., Metcalfe, D. D. (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcRI or FcRI. Leuk. Res. 27, 677-682.
29. Kirshenbaum, A. S., Kessler, S. W., Goff, J. P., Metcalfe, D. D. (1991) Demonstration of the origin of human mast cells from CD34 bone marrow progenitor cells. J. Immunol. 146, 1410-1415.
30. Hershko, A. Y., Suzuki, R., Charles, N., Alvarez-Errico, D., Sargent, J. L., Laurence, A., Rivera, J. (2011) Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis. Immunity 35, 562-571.
31. Kuehn, H. S., Beaven, M. A., Ma, H. T., Kim, M. S., Metcalfe, D. D., Gilfillan, A. M. (2008) Synergistic activation of phospholipases Cg and Cb: a novel mechanism for PI3K-independent enhancement of Fc_RI-induced mast cell mediator release. Cell. Signal. 20, 625-636.
32. Nguyen, M., Solle, M., Audoly, L. P., Tilley, S. L., Stock, J. L., McNeish, J. D., Coffman, T. M., Dombrowicz, D., Koller, B. H. (2002) Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production. J. Immunol. 169, 4586-4593.
33. Williams, T. J., Lewis, G. P. (1976) Proceedings: The pro-inflammatory activity of E-, A-, D- and F-type prostaglandins and analogues 16, 16-dimethyl- PGE2 and (15S)-15-methyl-PGE2 in rabbit skin; the relationship between potentiation of plasma exudation and local blood flow changes. Br. J. Pharmacol. 56, 341P-342P.
34. Kuehn, H. S., Radinger, M., Brown, J. M., Ali, K., Vanhaesebroeck, B., Beaven, M. A., Metcalfe, D. D., Gilfillan, A. M. (2010) Btk-dependent Rac activation and actin rearrangement following Fc_RI aggregation promotes enhanced chemotactic responses of mast cells. J. Cell Sci. 123, 2576-2585.
35. Gri, G., Piconese, S., Frossi, B., Manfroi, V., Merluzzi, S., Tripodo, C., Viola, A., Odom, S., Rivera, J., Colombo, M. P., Pucillo, C. E. (2008) CD4_CD25_ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29, 771-781.
36. Csaba, G., Török, O. (1977) The effect of cyclic AMP on the maturation and degranulation of mast cells. Acta Biol. Acad. Sci. Hung. 28, 153-156.
37. Odom, S., Gomez, G., Kovarova, M., Furumoto, Y., Ryan, J. J., Wright, H. V., Gonzalez-Espinosa, C., Hibbs, M. L., Harder, K. W., Rivera, J. (2004) Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med. 199, 1491-1502.
38. Mosenden, R., Taskén, K. (2011) Cyclic AMP-mediated immune regulation- overview of mechanisms of action in T cells. Cell. Signal. 23, 1009-1016.
39. Suzuki, R., Liu, X., Olivera, A., Aguiniga, L., Yamashita, Y., Blank, U., Ambudkar, I., Rivera, J. (2010) Loss of TRPC1-mediated Ca2+ influx contributes to impaired degranulation in Fyn-deficient mouse bone marrow- derived mast cells. J. Leukoc. Biol. 88, 863-875.
40. Janiszewski, J., Huizinga, J. D., Blennerhassett, M. G. (1992) Mast cell ionic channels: significance for stimulus-secretion coupling. Can. J. Physiol. Pharmacol. 70, 1-7.
41. Goulet, J. L., Pace, A. J., Key, M. L., Byrum, R. S., Nguyen, M., Tilley, S. L., Morham, S. G., Langenbach, R., Stock, J. L., McNeish, J. D., Smithies, O., Coffman, T. M., Koller, B. H. (2004) E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J. Immunol. 173, 1321-1326.
42. Foudi, N., Kotelevets, L., Louedec, L., Leséche, G., Henin, D., Chastre, E., Norel, X. (2008) Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype. Br. J. Pharmacol. 154, 1631-1639.
43. Luschnig-Schratl, P., Sturm, E. M., Konya, V., Philipose, S., Marsche, G., Fröhlich, E., Samberger, C., Lang-Loidolt, D., Gattenlöhner, S., Lippe, I. T., Peskar, B. A., Schuligoi, R., Heinemann, A. (2011) EP4 receptor stimulation down-regulates human eosinophil function. Cell. Mol. Life Sci. 68, 3573-3587.
44. Hata, A. N., Breyer, R. M. (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103, 147-166.
45. Breyer, M. D., Breyer, R. M. (2001) G protein-coupled prostanoid receptors and the kidney. Annu. Rev. Physiol. 63, 579-605.
46. Qian, X., Zhang, J., Liu, J. (2011) Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway. J. Biol. Chem. 286, 2111-2120.
47. Weston, M. C., Peachell, P. T. (1998) Regulation of human mast cell and basophil function by cAMP. Gen. Pharmacol. 31, 715-719.
48. Gilfillan, A. M., Rivera, J. (2009) The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 228, 149-169.
49. Yeo, M. G., Oh, H. J., Cho, H. S., Chun, J. S., Marcantonio, E. E., Song, W. K. (2011) Phosphorylation of Ser 21 in Fyn regulates its kinase activity, focal adhesion targeting, and is required for cell migration. J. Cell. Physiol. 226, 236-247.
50. Sibilano, R., Frossi, B., Suzuki, R., D'Inca, F., Gri, G., Piconese, S., Colombo, M. P., Rivera, J., Pucillo, C. E. (2012) Modulation of Fc_RI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA. J. Allergy Clin. Immunol. doi: 10.1016/j.jaci. 2012.03.032 [Epub ahead of print].
51. Duffy, S. M., Lawley, W. J., Conley, E. C., Bradding, P. (2001) Resting and activation-dependent ion channels in human mast cells. J. Immunol. 167, 4261-4270.
52. Duffy, S. M., Berger, P., Cruse, G., Yang, W., Bolton, S. J., Bradding, P. (2004) The K1 channel IKCa1 potentiates Ca21 influx and degranulation in human lung mast cells. J. Allergy Clin. Immunol. 114, 66-72.